Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Kezar Life Sciences, Inc. (KZR) had Free Cash Flow per Share of $-4.10 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-13.70M |
|
-- |
|
-- |
|
$14.60M |
|
$-14.60M |
|
$0.90M |
|
$-13.70M |
|
$-13.70M |
|
$-13.70M |
|
$-13.70M |
|
$-13.70M |
|
$-13.70M |
|
$-14.60M |
|
$-14.90M |
|
7.31M |
|
7.31M |
|
$-1.87 |
|
$-1.87 |
|
| Balance Sheet Financials | |
$104.70M |
|
$2.41M |
|
$4.42M |
|
$109.12M |
|
$14.37M |
|
$2.63M |
|
$2.97M |
|
$17.34M |
|
$91.79M |
|
$91.79M |
|
$91.79M |
|
7.32M |
|
| Cash Flow Statement Financials | |
$-29.98M |
|
$25.14M |
|
$-2.57M |
|
$41.75M |
|
$34.37M |
|
$-7.38M |
|
$5.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.29 |
|
-- |
|
-- |
|
0.03 |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-29.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.93% |
|
-14.93% |
|
-12.56% |
|
-14.51% |
|
$12.55 |
|
|
Free Cash Flow per Share |
$-4.10 |
$-4.10 |
|